Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Xuemin Zhu

Dr Xuemin Zhu

Xuemin Zhu



Xuemin Zhu joined HERC in April 2023 as a researcher. Xuemin’s current work focuses on the health economic analysis of StereoTactic radiotherapy for wet age-related macular degeneration and the psychometric assessment of health outcome measures such as EQ-5D, EQ-5D-Y, EQ-HWB and ASCOT in rare genetic diseases.

Prior to her current position, Xuemin worked as a research assistant at the Vanke School of Public Health, Tsinghua University. During her time there, she used health insurance data to evaluate the impacts of the pandemic and a long-term care insurance pilot on healthcare usage. Xuemin completed her PhD in Health Economics from the University of Aberdeen, with a thesis exploring the role of physicians’ risk attitudes and personality traits on decision-making. She was awarded an MSc in Health Economics from the University of York with a thesis focusing on the role of time preference on time trade-off values. Xuemin obtained her BSc in International Economics and Trade (Medical direction) from the China Pharmaceutical University.

Xuemin’s research interests include economic evaluations and stated preference studies, policy evaluation and non-cognitive skills in decision-making.